The registry is designed to monitor the safety and efficacy of a minimally invasive heart therapy for aortic stenosis called transcatheter aortic valve replacement therapy, which was approved by the FDA last month. The registry will capture all clinical data related to TAVR and has the ability to incorporate catheter-based procedures not yet available in the United States.
The TVT Registry will also link to the Social Security Death Master File and CMS’ databases to provide long-term outcomes data.
Related Articles on Hospital Cardiology:
Study: Less Than 10% of Hospitals Meet Recommended Timeline for Transferring Cardiac Patients
Many Physicians Unaware of National Guidelines for Sudden Cardiac Death Screening
Cardiology Organizations Release New Guidelines for Coronary Revascularization Treatment
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
